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Beyond sample curation and basic pathologic characterization, the digitized H&E-stained images
of TCGA samples remain underutilized. To highlight this resource, we present mappings of tumorinfiltrating lymphocytes (TILs) based on H&E images from 13 TCGA tumor types. These TIL
maps are derived through computational staining using a convolutional neural network trained to
classify patches of images. Affinity propagation revealed local spatial structure in TIL patterns and
correlation with overall survival. TIL map structural patterns were grouped using standard
histopathological parameters. These patterns are enriched in particular T cell subpopulations
derived from molecular measures. TIL densities and spatial structure were differentially enriched
among tumor types, immune subtypes, and tumor molecular subtypes, implying that spatial
infiltrate state could reflect particular tumor cell aberration states. Obtaining spatial lymphocytic
patterns linked to the rich genomic characterization of TCGA samples demonstrates one use for
the TCGA image archives with insights into the tumor-immune microenvironment.

In Brief
Tumor-infiltrating lymphocytes (TILs) were identified from standard pathology cancer images by
a deep-learning-derived “computational stain” developed by Saltz et al. They processed 5,202
digital images from 13 cancer types. Resulting TIL maps were correlated with TCGA molecular
data, relating TIL content to survival, tumor subtypes, and immune profiles.
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Although studies in humans have shown that chronic inflammation can promote
tumorigenesis (Trinchieri, 2012), the host immune system is equally capable of controlling
tumor growth through the activation of adaptive and innate immune mechanisms (Galon et
al., 2013). Such intratumoral processes are often referred to collectively as immunoediting,
where this selective pressure can result in the emergence of tumor cells that escape immune
surveillance and, ultimately, to tumor progression. At the same time, many observations
suggest that high densities of tumor-infiltrating lymphocytes (TILs) correlate with favorable
clinical outcomes (Mlecnik et al., 2011a) such as longer disease-free survival or improved
overall survival (OS) in multiple cancer types (Angell and Galon, 2013). Recent studies
further suggest that the importance of spatial context and the nature of cellular heterogeneity
of the tumor microenvironment, in terms of the immune infiltrate involving the tumor center
and/or invasive margin, can also correlate with cancer prognosis (Fridman et al., 2012).
Prognostic factors, most notably the Immunoscore, that quantify such spatial TIL densities
in different tumor regions have high prognostic value that can significantly supplement and
sometimes even supersede the standard TNM classification and staging in certain
settings(Galon et al., 2006; Broussard and Disis, 2011; Mlecnik et al., 2011b). Given this
and the central role of immunotherapy treatments in contemporary cancer care, these
assessments of tumor-associated lymphocytes are increasingly important both in the clinical
assessment of pathology slides, as well as in translational research into the role of these
lymphocytic populations.
Tissue diagnostic studies are carried out and interpreted by pathologists for virtually all
cancer patients, and the overwhelming majority of these are stained with hematoxylin and
eosin (H&E). The TCGA Pan Cancer Atlas dataset includes representative H&E diagnostic
whole-slide images (WSIs) that enable spatial quantification and analysis of TILs and
association with the wealth of molecular characterization conducted through the TCGA.

Cell Rep. Author manuscript; available in PMC 2018 May 10.
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Previously, this rich trove of imaging data has primarily been used solely to qualify samples
for TCGA analysis and gleaning of some limited histopathologic parameters by expert
pathologists. Using digital pathology and digitized whole-slide diagnostic tissue images,
machine learning and deep learning approaches can create a “Computational Stain.” This
allows identification and quantification of image features to formulate higher-order
relationships that go beyond simple densities (e.g., of TILs) to explore quantitative
assessments of lymphocyte clustering patterns, as well as characterization of the
interrelationships between TILs and tumor regions. We apply this to the TCGA samples in a
broad multi-cancer fashion. Only a few TCGA tumor types have been explored for TIL
content based on feature extraction from histologic H&E images and in a more limited
fashion (Rutledge et al., 2013; Cancer Genome Atlas Research Network, 2017).
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Over the past 12 years, The Cancer Genome Atlas (TCGA) has profoundly illuminated the
genomic landscape of human malignancy. More recently, it has been recognized that
genomic data derived from bulk tumor samples, which include the tumor stromal, vascular,
and immune compartments, as well as tumor cells, can provide detailed information about
the tumor immune microenvironment. Molecular subtypes of ovarian, melanoma, and
pancreatic cancer have been defined based on measures of immune infiltration (Cancer
Genome Atlas Research Network, 2011; Cancer Genome Atlas Network, 2015; Bailey et al.,
2016), and a number of other tumors show variation in immune gene expression by
molecular subtype (Iglesia et al., 2014, 2016; Kardos et al., 2016). Recent publications
(Charoentong et al., 2017; Li et al., 2016; Rooney et al., 2015) have presented
comprehensive analyses of TCGA data on the basis of immune content response. A recent
study (Thorsson et al., 2018) reports on a series of immunogenomic characterizations that
include assessments such as total lymphocytic infiltrate, immune cell type fractions, immune
gene expression signatures, HLA type and expression, neoantigen prediction, T cell and B
cell repertoire, and viral RNA expression. From these base-level results, integrative analyses
were performed to derive six immune subtypes, spanning tumor types and subtypes. The
comprehensive pairing of clinical, sample, molecular tumor, and immune characterizations
with H&E WSIs in the TCGA is a unique resource (Cooper et al., 2017) and offers the
possibility of identifying relationships between computational staining of whole-slide
images and other measures of immune response that may in turn inform research into
immuno-oncological therapy. In this work, we characterize spatial patterns of TILs and
present relationships between TIL patterns and immune subtypes, tumor types, immune cell
fractions, and patient survival, illustrating the potential of this kind of analysis and the kinds
of questions that can be explored. For example, through integration of spatial patterns with
molecular TIL characterization, we found evidence for these patterns being enriched in
particular T cell populations.
This study represents an important milestone in the use of digital-pathology-based
quantification as we are able to present results relating spatial and molecular tumor immune
characterizations for roughly 5,000 patients with 13 cancer types. TILs and spatial
characterizations of TILs have shown significant value in diagnostic and prognostic settings,
and the ability to quantify TILs from diagnostic tissue has proven to be demanding,
expensive, challenging to scale, and beleaguered by subjectivity. Human review of
diagnostic tissue is highly effective for traditional diagnosis but is qualitative and thus is
Cell Rep. Author manuscript; available in PMC 2018 May 10.

Saltz et al.

Page 5

Author Manuscript

prone to both inter- and intra- observer variability, particularly when attempting to quantify
or reproducibly characterize feature-rich phenomena such as tumor-associated lymphocytic
infiltrates. The spatial characterizations we present are high resolution, with TIL infiltration
assessed in whole-slide images at a 50-micron resolution, and all TIL maps are available to
the scientific community for further exploration. The recent FDA approval (FDA News
Release, 2017) of whole-slide imaging for primary diagnostic use is leading to more
widespread adoption of digital whole-slide imaging. It is widely expected that, within 5–10
years, the great majority of new pathology slides will be digitized, thus enabling the
development and clinical adoption of various digital-pathology-based diagnostic and
prognostic biomarkers that will likely provide decision support for traditional pathologic
interpretation in the clinical setting.

RESULTS
Author Manuscript

Generating Maps of Tumor-Infiltrating Lymphocytes using Convolutional Neural Networks
In order to accurately generate maps of tumor-infiltrating lymphocytes (TIL Maps) from
digitized H&E stained tissue specimens, we developed a comprehensive methodology and
accompanying interactive tools. This methodology is termed Computational Staining and
employs deep learning methods to analyze images and tools to incorporate expert feedback
into the deep learning models. Such iterative feedback results in the improvement of the
overall accuracy of TIL Maps. Key highlights and the validation strategy for Computational
Staining are presented here, with further details provided in the Method Details.

Author Manuscript
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Computational Staining uses convolutional neural networks (CNNs) to identify lymphocyteinfiltrated regions in digitized H&E stained tissue specimens. The CNN is a supervised deep
learning method that has been successfully applied in a large number of image analysis
problems (Cireşan et al., 2013; Huang et al., 2016; Xie et al., 2015a, 2015b; Wang et al.,
2016; Sirinukunwattana et al., 2016; Bayramoglu and Heikkila, 2016; Su et al., 2015; Hou et
al., 2016a; Murthy et al., 2017;Chen et al., 2017; Xu and Huang, 2016). A CNN first uses a
set of training data to learn a classification (or predictive) model in the training phase. The
resulting trained model is then used to classify new data elements in a prediction phase.
Deep-learning-based automatic analysis methods generally require large annotated datasets.
Many state-of-the-art methods employ semi-supervised training strategies to boost trained
model performance using unlabeled data (Ranzato et al., 2006; Masci et al., 2011;
Bayramoglu and Heikkila, 2016; Xu and Huang, 2016; Su et al., 2015). They (1) pre-train an
autoencoder for unsupervised representation learning; (2) construct a CNN from the
pretrained autoencoder; and (3) fine-tune the constructed CNN for supervised classification.
One can train the unsupervised autoencoder on image patches with the object to be classified
(e.g., nucleus) in the center of each patch (Hou et al., 2016a; Murthy et al., 2017) in order to
capture the visual variance of the object more accurately. This method, however, requires a
separate object detection step. Instead of tuning the detection and classification modules
separately, recent studies (Graves and Jaitly, 2014; Ren et al., 2015; Redmon et al., 2016;
Kokkinos 2017) have developed CNNs to perform these tasks in a unified but fully
supervised pipeline.

Cell Rep. Author manuscript; available in PMC 2018 May 10.

Saltz et al.

Page 6

Author Manuscript

Our methodology uses two CNNs: a lymphocyte infiltration classification CNN (lymphocyte
CNN) and a necrosis segmentation CNN (necrosis CNN). The lymphocyte CNN categorizes
tiny patches of an input image into those with lymphocyte infiltration and those without. It is
a semi-supervised CNN, initialized by an unsupervised convolutional autoencoder (CAE).
The necrosis CNN segments the regions of necrosis and is designed to eliminate false
positives from necrotic regions where nuclei may have characteristics similar to those in
lymphocyte-infiltrated regions. Details about the two CNNs are shown in Figure S1A and
described in the Method Details.
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Figure 1 illustrates both the training and model development phase of our methodology (top
half of the figure) and the use of the trained model to generate TIL Maps (bottom half of the
figure). The CNN training and model development phase starts with expert pathologists
reviewing a set of images and marking regions of lymphocytes and necrosis. The
lymphocyte and necrosis regions are then subdivided into tiny patches to create the initial
training dataset. Training with patches rather than with individual regions and cells is done
for computational efficiency. The lymphocyte CNN is trained with 50 × 50 μm2 patches
(equivalent to 100 × 100 square pixel patches in tissue images acquired at 20× magnification
level) from WSIs. The necrosis CNN is trained with larger patches of size 500 × 500 μm2, as
more contextual information results in superior prediction of patches being necrotic. The
initial training step is followed by an iterative cycle of review and refinement steps to
improve the prediction accuracy of the lymphocyte CNN. This prediction step generates a
probability value of lymphocyte infiltration for each patch in the images. The patch-level
predictions for an image are combined and represented to pathologists as a heatmap for
review and visual editing using our TIL-Map editor tool. The pathologists refine the CNN
predictions for an image by first adjusting the probability value threshold (which globally
updates the labels of the patches in the image; if the probability value of a patch exceeds the
adjusted threshold, the patch is labeled a TIL patch) and then manually editing the heatmap
to correct prediction errors for individual or groups of patches. At the end of the editing step,
the updated heatmaps are processed to augment the training dataset. The lymphocyte CNN
is re-trained with the updated training dataset. This iterative process continues until adequate
prediction accuracy is achieved, as determined by the pathologist feedback. The necrosis
CNN was retrained only once in this study, because it achieved sufficient prediction
accuracy. The training and re-training steps of both CNNs involve cross-validation to assess
prediction performance and avoid overfitting (Hou et al., 2017). See the Method Details for
an in-depth description of this process.

Author Manuscript

The trained models are used on test datasets (bottom half of Figure 1). In this work, we
applied our method to 5,455 diagnostic H&E WSIs from 13 TCGA tumor types in which
lymphocytes are known to be present. See Additional Resources for listing and acronyms.
We included uveal melanoma (UVM) as one of the 13 cancer types essentially as a type of
negative control (Figure S3A), since it has the fewest immune cells among TCGA tumors
(Thorsson et al., 2018). Tumor types were selected to represent a range of known positive
involvement of lymphocytes and immunogenicity from literature and from molecular
estimates of lymphocyte content. Each image was partitioned into patches of 50 × 50 μm2
and each patch was classified by the CNNs. TIL maps were successfully generated (see
Figure S1C and Table S2) for 5,202 TCGA tumor images from 4,759 individual participants
Cell Rep. Author manuscript; available in PMC 2018 May 10.
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in the 13 tumor types. 253 images (4.6%) did not yield TIL maps because of low image
quality or low prediction accuracy or because the images were duplicates (see Figure S1C).

Author Manuscript

We assessed the performance of our approach in two complementary, yet orthogonal ways.
The first assessment method, described in Zhao et al. (2017), compares performance
prediction of our method with that of a popular and widely used CNN—called VGG16
(Simonyan and Zisserman, 2014)—using a set of WSIs from TCGA lung adenocarcinoma
(LUAD) cases. The training set of the lymphocyte CNN consisted of 20,876 patches. Each
patch usually contains 0 to 30 nuclei and was annotated by a pathologist as lymphocyte
infiltrated or not lymphocyte infiltrated. The training set of the necrosis segmentation CNN
consisted of 1,800 patches. Each patch was annotated with a necrosis region mask
segmented by a pathologist. We sampled 2,480 patches to create the test dataset. The ROC
curve shows that our approach slightly outperforms VGG16 by 3.1% with respect to the area
under ROC curve (AUROC) metric (Figure 2A). We also performed direct comparison of
TIL patch assignments by the Computational Staining pipeline with those by experienced
pathologists by scoring 8 × 8 “super-patches” for TIL content. Three pathologists assessed
400 super-patches as having low, medium, or high TIL content, while machine-derived
scores were assigned for the patch by counting TIL-positive patches (thus ranging from 0 to
64). Consistency was high among each of the pathologists (> 80%), as assessed by rescoring
of 100 super-patches. As seen in Figure 2B, the median machine-derived score is quite
distinct between the three ordinal bins. This is evidenced in strong correlation as assessed by
the polyserial coefficient (Drasgow, 2014), designed for comparing ordinal with continuous
values (0.36 with 95% CI [0.27,0.45], p value = 5.2 × 10−15, R package polycor).
Assessment and Correlates of TIL Spatial Fraction

Author Manuscript
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Spatial Fraction of TILs—The spatial fraction of TILs was estimated as the fraction of
TIL-positive patches among the total number of patches identified on the tissue sample. A
wide range in spatial infiltrate is seen among the TCGA tumor types (Figure 3A and Table
S1), with high infiltrates in gastric cancer (STAD) with a mean of 14.6%, rectal cancer
(READ) at 13.0%, squamous cell carcinoma in the lung (LUSC) at 11.6%, while uveal
melanoma (UVM) has only 1% estimated TIL fraction, consistent with its inclusion as
negative control (Figure S3A). Wide differences are also seen grouping tumors by the nature
of the immune response, according to a recent immune characterization of all TCGA tumors
(Thorsson et al., 2018)(Figure 3B). The most immunologically active immune subtypes
(e.g., C1, C2) tend to have the greatest spatial infiltration of lymphocytes. Within
documented TCGA subtypes, which are typically characterized by specific molecular
changes in tumor cells, strong differences are also seen (Figure S2A). EBV-positive gastric
cancer is particularly rich in TILs, with an average of 25% of spatial regions infiltrated by
TILs (Figure 3C). The lung squamous secretory subtype (Wilkerson et al., 2010) is also
particularly rich in infiltrate (17%, Figure 3D) as is the mutation-rich POLE subtype of
endometrial cancer. Among breast cancer tumors, the basal subtype has the greatest infiltrate
(Figure 3E), consistent with what has been observed in other studies (Iglesia et al., 2014).
Taken together, these data show that the nature of the infiltrate has strong ties to aspects of
the tumor microenvironment and that the nature of the infiltrate may be reflective of
particular molecular aberration states of tumor cells.

Cell Rep. Author manuscript; available in PMC 2018 May 10.
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The spatial fraction of TILs was compared with molecular estimates of TIL content from
molecular genomics assays (Thorsson et al., 2018). The molecular estimate of TIL fraction
is obtained by multiplying an estimate of the overall leukocyte fraction, based on DNA
methylation arrays, with an estimate of the lymphocyte proportion within the immune
compartment obtained by applying CIBERSORT (Newman et al., 2015) to RNA sequencing
data. Good, albeit imperfect, agreement is seen between the imaging and molecular
estimates (Figure 4A), with Spearman correlation values ranging from 0.20 to 0.45 for the
most part accompanied by highly significant p values, and with UVM, the negative control,
showing no correlation. The reasons for the differences between the molecular estimates and
spatial TIL fraction include: (1) molecular data are extracted from a fresh frozen tissue
section in proximity to the formalin-fixed paraffin-embedded (FFPE) sample used to
generate the diagnostic H&E image, but the exact spatial relation is unknown; (2) the
molecular estimate is proportional to the number of lymphocytes, whereas the spatial
fraction of TILs is estimated by tissue area; (3) the spatial analysis and TIL fraction are an
assessment of lymphocyte-infiltrated tissue that can also include non-tumor regions on the
diagnostic slides; and (4) the molecular quantification is obtained from frozen sections that
are highly enriched for tumor as a criterion for project inclusion. We further examined the
outlier cases (see Figures 4B and 4C) having high levels of discordance between molecular
and spatial image-derived TIL estimates for several tumor types, including BRCA, SKCM,
LUAD, LUSC, STAD, and READ. We determined that spatial TILs in non-tumor regions
appeared to play a major explanatory role (Figures S3B and S3C). Attempts to exclude such
areas by manual negative masking and/or CNN-based automation for tumor recognition will
be included in future efforts in order to reduce the discordance between the molecular
estimates from samples that are highly enriched for tumor and the spatial TIL estimates
derived from diagnostic H&E images.

Author Manuscript

Automated Assessment of Local Structures in the TIL Infiltrate and Association with
Molecular and Clinical Readouts

Author Manuscript

Local Spatial Structure of the Immune Infiltrate—A unique feature of imaging data
is the ability to go beyond total lymphocytic infiltrate load to the assessment of patterns of
lymphocytic infiltration. To identify such patterns, we first used affinity propagation (Frey
and Dueck, 2007) to find spatially connected and coherent regions (clusters) of TIL image
patches (APCluster R package; Bodenhofer et al., 2011). Examples of H&E images, TIL
maps, and clusters are shown in Figures 5A–5D for selected cases exemplifying sparse and
dense lymphocyte infiltrates. For each slide, the resulting cluster pattern was characterized
using measures for simple count and extent statistics but also by clustering indices, which
assess more complex characteristics such as cluster shape. Summary measures include the
number of clusters Ncluster, the mean number of TIL patches in the clusters NP, the mean of
the within-cluster dispersion WCD, and the mean of cluster spatial extents CE (see Figure
5E, Method Details, and Table S1). In terms of TIL patch distances to a given cluster center,
the dispersion is related to their variance, while spatial extent is akin to the maximal
distance. Ncluster ranged from 2 to 46 over the entire cohort (4,480 cases, excluding nontumor slides), with a median of 12, and the mean cluster membership was 293 TIL patches.
We calculated the clustering indices of Ball and Hall (1965), Banfield and Raftery (1993),
the C index, and the determinant ratio index, as implemented in the R package clusterCrit
Cell Rep. Author manuscript; available in PMC 2018 May 10.
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(see Method Details and Table S1). The Ball-Hall index is the mean of the dispersion
through all of the clusters, equivalent to the mean of the squared distances of the points of
the cluster with respect to its center. In our data, the Ball-Hall index is correlated (ρSpearman
= 0.95) with the mean cluster extent, CE. The Banfield-Raftery index is the weighted sum of
the logarithms of the mean cluster dispersion, which in our data correlates with Ncluster
(ρSpearman = 0.95). We found similarity among several of the various scores (Figure S4A),
including overall trending of some clustering indices to simpler measures such as Ncluster
and TIL fraction. The C index is derived from pairwise distances and does not scale with any
of the simpler measures. Values of these scores for the cases depicted in Figures 5A–5D are
shown in Figure 5E. Clustering indices vary widely over slides, as illustrated in Figure 6A
for the Ball-Hall index. Tumors with relatively high values of this index, such as BRCA and
PRAD, are not among those with highest overall infiltrate (Figure 3A). Since the Ball-Hall
index scales with approximately cluster extent, this implies that, in some of these tumor
types of moderate infiltrate mass, TIL clusters of relatively large spatial extent are formed.
In summary, this implies that, in some tumor types, local clustering of TILs may be a more
distinctive feature than overall TIL infiltrate, in comparison with other tumor types.
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Correlates of Local TIL Spatial Structure with Survival—We examined the extent to
which TIL fraction might impact overall survival and the extent to which spatial
characteristics of the tumor microenvironment—beyond overall densities—may provide
additional predictive power of outcome. We used Cox regression, accounting for age and
gender as additional clinical covariates to perform survival analysis. In order to mitigate
possible problems in interpretation due to the inherent correlation between some clustering
indices and the TIL densities, we used linear regression to obtain adjusted cluster indices by
computing residuals with respect to TIL density (see Method Details). p values were
obtained for four adjusted indices and 13 tumor types, which were then adjusted for multiple
testing using the Benjamini-Hochberg procedure. Five associations between cluster index
and outcome were significant (at p < 0.05) and are shown in Figure 6B. Interestingly, the
various indices were significant across different tumor types. Examples of Kaplan-Meier
curves for median-split clustering indices are shown in Figures 6C (BRCA) and 6D
(SKCM). In SKCM, increased Banfield Raftery-index (“cluster count”) associates with
superior survival, while in BRCA increased Ball-Hall index (“cluster extent”) associates
with inferior survival, both adjusted for overall TIL density. Of interest, checkpoint
inhibition immunotherapy has been successfully applied to melanoma, while breast cancer
tumors have generally been unresponsive to checkpoint blockade therapy. The association of
structure with survival, as evidenced by less favorable survival in tumors with elevated
adjusted Ball-Hall index (“cluster extent”) could be worthy of further investigation as a
stratification factor for patient tumors in clinical studies of response.
Characterization of Overall TIL Map Structural Patterns and Association with Molecular
Estimates
We undertook further characterization of TIL spatial structure, looking beyond local spatial
structures toward a global structure classification that reflects standard descriptions in
current use by practicing pathologists. We incorporated qualitative and semiquantitative
descriptions and scoring of the TIL map structural patterns in the combined intratumoral and
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peri-tumoral regions (collectively referred to as “tumor”) that are grossly defined by the
corresponding H&E-stained whole-slide images.
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Author Manuscript

As seen in the recommendations from of the International TILs Working Group (Salgado et
al., 2015), International Immuno-oncology Biomarkers Working Group (Hendry et al.,
2017a, 2017b), and the prognostic descriptions used to characterize TILs in cutaneous
melanoma (Crowson et al., 2006), pathologists classify patterns within the TIL maps in both
the intratumoral and peritumoral regions. Correspondingly, patterns in the 5,202 TIL maps
were visually assigned by a pathologist into one of five categories: “Brisk, diffuse” for
diffusely infiltrative TILs scattered throughout at least 30% of the area of the tumor (1,856
cases); “Brisk, band-like” for immune responses forming band-like boundaries bordering the
tumor at its periphery (1,185); “Non-brisk, multi-focal” for loosely scattered TILs present in
less than 30% but more than 5% of the area of the tumor (1,083); “Non-brisk, focal” for
TILs scattered throughout less than 5% but greater than 1% of the area of the tumor (874);
and finally “None” in 143 cases where few TILs were present involving 1% or less of the
area of the tumor (see Method Details). TIL maps with corresponding H&E images with
insufficient or no grossly identifiable tumor at low magnification were designated as
indeterminate (61). The examples in Figures 5A–5D are categorized as follows: Figure 5A,
TCGA-33-AASL Brisk, diffuse pattern in a case of squamous cell carcinoma of the lung
showing a relatively strong immune infiltrate within the tumor; Figure 5B, TCGA-D3-A2JF
Brisk, band-like pattern in a case of cutaneous melanoma showing immune infiltrates
forming boundaries bordering the tumor at its periphery and < 30% TILs in the intratumoral
component; Figure 5C, TCGA-E9-A22H Non-brisk, multi-focal pattern in a case of invasive
ductal carcinoma of the breast showing a weak immune response with loosely scattered
TILs; Figure 5D, TCGA-EW-A1OX Non-brisk, focal pattern in a case of invasive ductal
carcinoma of the breast showing a very weak immune response in a focal area (categories
also listed in final column of Figure 5E).
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The TIL map global patterns are not distributed in an equal manner among TCGA tumor
types. Figure 7A shows the ratio of observed counts over those expected randomly. BRCA is
enriched in the “Non-brisk, focal” phenotype (374 observed; 166 expected; p value < 3 ×
10−16, Fisher’s exact test, Benjamini-Hochberg adjusted). PAAD is enriched in the “Nonbrisk, multi-focal” phenotype (70 observed; 36 expected; p = 8 × 10−8), as is PRAD (151;
70; p < 3 × 10−16). The “Brisk, band-like” phenotype is most enriched in SKCM (134; 86; 3
× 10−7) and very rare in PAAD (7; 37; 2 × 10−9) and PRAD, whereas “Brisk, diffuse” is
more prevalent in STAD, READ, and CESC (p = 2 × 10−13, 4 × 10−6, and 3 × 10−10,
respectively). Some TCGA subtypes also show enrichment in particular patterns (Figure
S5A). For example, EBV-positive GI cancers are enriched in the “Brisk, diffuse” phenotype
(14; 5; 6 × 10−3). Differences are also seen among immune subtypes (Figure S5B) defined in
the TCGA pan-immune analysis (Thorsson et al., 2018), where the C4 subtype is enriched in
the “Non-brisk, focal” (82; 44; 6 × 10−8). This is noteworthy, as subtype C4 is relatively
richer in cells of the monocyte/macrophage lineage, which may play a role in sculpting the
TME as evidenced in these patterns. Interestingly, the immune subtype C3, which tends to
have good prognosis overall, has relatively few “Brisk band-like” structures (59; 162; < 3 ×
10−16), perhaps reflective of the more moderate and tempered immune response or
productive infiltration of lymphocytes into tumor regions. C2, which has relatively poor
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outcome, is somewhat richer in “Brisk” phenotypes, consistent with expectations that the
relatively large degree of lymphocytic infiltrates are not adequately controlling tumor growth
in this class of tumors. In summary, the global structural patterns show associations with
distinct immune responses that can be either particular to subtypes, or shared across multiple
tumor types, and may play a role in the determining the nature of the immune responses in
the corresponding tumor microenvironments.
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We also examined whether there was evidence of differences in the types of lymphocytes,
such as signatures for CD4 T cells, CD8 T cells, B cells, and NK cells, represented in each
phenotype. These cells cannot be distinguished by the H&E image analysis, but estimates of
their proportions are available through analysis of the molecular data (Thorsson et al., 2018
and Method Details). Averaging these values within structural patterns, we see emerging
relationships (Figures 7B and S5C), where “Brisk” phenotypes have a higher proportion of
CD8 T cells than those seen in the “Non-Brisk” phenotypes (mean 13.2% versus 10.7%, p
value < 2.2 × 10−16, Mann–Whitney–Wilcoxon test). Correspondingly, “Non-Brisk”
phenotypes tend to have a slightly greater proportion of CD4 T cells (p = 0.03). Thus, by
combining molecular estimates of cell proportion with structural analysis of imagining data,
we see evidence that particular T cell subsets may play distinct roles in the formation of
global structural patterns.

DISCUSSION
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The scanned archival H&E archives of the TCGA are a rich but quite underutilized resource
within this project. In effect, it is a largely ignored source of data that has only been
manually and sporadically mined and awaits more systematic characterization using the
variety of analytic tools and analyses currently available. These images have generally been
used solely to ensure the correct diagnosis, and panels of expert pathologists also used the
images to glean other variables such as mitotic activity, tumor grade, and histologic subtypes
for some of the TCGA marker papers. The recently published sarcoma TCGA marker paper
utilized automated feature extraction of nuclear properties for correlation with copy number
load and genomic doubling (Cancer Genome Atlas Research Network, 2017). The cutaneous
melanoma TCGA marker paper used a visual inspection of expert pathologists to assess the
degree and pattern of lymphocytes in the frozen section images of the tissue going to the
molecular platforms to correlate with other genomic and proteomic assessments of
lymphocytic infiltrate and also directly with clinical outcome (Cancer Genome Atlas
Network, 2015). This was a manual process done by expert pathologists, and there was no
attempt at automation. The efforts presented in this present work represent an initial attempt
to systematically employ automated image processing to assess lymphocytic infiltrates
across multiple TCGA tumor types for correlation with genomic and epigenomic
assessments of lymphocytic infiltrates, as well as clinical outcome. Our sincere hope is that
this early attempt to exploit this remarkable TCGA resource of associated scanned histologic
images will spur others to similar approaches.
We report a scalable and cost-effective methodology for computational staining to extract
and characterize lymphocytes and lymphocytic infiltrates in intratumoral, peri-tumoral, and
adjacent stromal regions. In comparing TIL fraction identified via molecular methods to TIL
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maps derived from digital image analyses of H&E images, we found good but certainly not
perfect agreement. Several factors may be contributing. First, perfect agreement is not
expected, since the estimates being compared are not of the same quantity or source. Indeed,
the molecular estimates are analogous to cell count ratios, and the image fractions
correspond to the proportion of spatial areas that contain TILs. Second, the exact spatial
relation between the sample from which the molecular data is extracted (between the socalled frozen tissue top-section and bottom-section) and the diagnostic images from the
FFPE examples used to generate the diagnostic H&E slides is not known. The TIL maps are
derived from high-quality scanned diagnostic FFPE H&E slides from tissue samples in an
adjacent or possibly a more distant portion of the tumor relative to where the top and bottom
frozen sections are sampled. Unfortunately, the frozen section images are not of a quality
that permits robust features extraction. Even though some degree of correlation is certainly
expected since TIL status is often a property of the tumor as a whole, upon further
evaluation, we observed regional differences in a subset of samples within the overall
assessment. These differences are largely explained by the effect of spatial TILs in nontumor regions in the diagnostic H&E images, which appeared quite different than the spatial
TILs in the frozen section samples used for molecular TIL estimates.
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Integrated analysis of TIL maps and molecular data reveals patterns and associations that
can improve our understanding of the tumor microenvironment, and we illustrate some
emerging relationships in this work. Both local patterns and overall structural patterns are
differentially represented among tumor types, immune subtypes, and tumor molecular
subtypes, the latter of which are typically driven by particular molecular alterations in the
tumor cell compartment. This implies that the nature of spatial lymphocytic infiltrate state
may be reflective of particular aberration states of tumor cells. In some tumor types (such as
PAAD and PRAD), local clustering of TILs may be a more distinctive feature than overall
TIL infiltrate, as compared with other tumor types. Structural patterns are further seen to be
associated with survival, implying that the nature and effectiveness of immune response is
encoded in patterns that may be assessable at the time of tumor diagnosis. For example, in
breast cancer, less favorable survival in tumors with elevated adjusted Ball-Hall index
(“cluster extent”) might be worth further investigation in terms of stratification of patient
tumors in clinical studies of response. Overall structural patterns show associations with
immune responses that are shared across multiple tumor types and may thus play a role in
the determining the nature of those responses. For example, tumors with C2 immune
subtypes, which tend to have relatively poor outcome, are somewhat richer in “Brisk”
phenotypes, consistent with expectations that the relatively large degree of lymphocytic
infiltrates are not adequately controlling tumor growth in these tissues. The immune subtype
C3, which tends to have good prognosis overall, has fewer “Brisk band-like” structures,
perhaps reflective of the more moderate and tempered immune response, or productive
infiltration of lymphocytes into tumor regions. In contrast, tumors with the C4 immune
subtype, which tends to be rich in cells of the monocyte/macrophage lineage, tend to have
more “Non-brisk, focal” structures that may play a role in sculpting the TME as evidenced
in these patterns. Finally, these patterns are enriched in particular T cell subpopulations as
derived from molecular measures. For example, “Brisk” phenotypes have a higher
proportion of CD8 T cells than those seen in the “Non-Brisk” phenotypes.
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A number of factors can contribute to cancer patient outcome. In our analyses, we attempted
to control for age and sex, but other factors such as tumor grade could affect the presence or
function of tumor-infiltrating lymphocytes. Grade is more challenging to control for across
tumor types, as some are not graded such as melanoma while others such as breast and
prostate cancer have very different grading systems that are challenging to compare
rigorously. We readily accept that tumor grade and potentially other factors could influence
lymphocytic infiltrates in both degree and pattern.
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These analyses and early results demonstrate the vast potential of combining analysis of
spatial structure with advanced genomics and molecular assessment, as the TIL information
is being provided in the context of tumor molecular data wide in detail and in scope. The
TCGA molecular datasets and the characterizations performed on them through the work of
the PanCancer Atlas consortium, including those on the tumor-immune interface and the
tumor microenvironment, provide an extraordinarily rich source of correlative molecular
information for our discovered TIL patterns.

Author Manuscript

H&E imaging is performed routinely in labs throughout the world as a component of tumor
diagnostics. Methods for extracting information on TILs from H&E scanned images are
potentially of enormous research validity and possible clinical applicability—hundreds of
thousands of whole-slide images exist in public repositories, in hospital system databases,
and many more will be generated for years to come. In a clinical setting, rapid and
automated identification of the degree and nature of TIL infiltrate might be instrumental in
determining whether options for immunotherapy should be explored or whether more
detailed and costly immune diagnostics should be introduced. Indeed, our approach might
also complement immunophenotyping data, and the patterns of immune infiltration assessed
by pathologists are already widely employed in the standard clinical reports of primary
melanomas as a prognostic factor. Applying methods like those we present here could also
allow for very incisive research at very reasonable price points and levels of convenience.
These kinds of analyses can only improve with more detailed molecular-marker-based
assays such as immunohistochemistry, which are not currently applied in most standard
clinical settings due to lack of clinical necessity. Since the TCGA cohorts often predate the
broad clinical application of effective immunotherapy such as checkpoint inhibitors and
contain little data regarding outcomes with such therapy, association of our TIL estimates
and derived infiltration patterns await more appropriate datasets to test associations.
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We believe our CNN-derived TIL mapping provides a reproducible and robust tool for the
assessment of these lymphocytic infiltrates. The ability to assess this tumor feature is rapidly
becoming vital to both clinical diagnosis and translational research for onco-immunologic
cancer care. These results show that this approach correlates with molecular assessments of
TILs generated by the molecular platforms of the TCGA and can also correlates with
clinical outcome for certain tumor types. Importantly, this study shows the value of feature
extraction from the information-rich resource of the scanned H&E image archive of the
TCGA. This resource has not been exploited to the degree of the other TCGA molecular and
clinical outcome resource and clearly not to the degree it can support. This present study
demonstrates value that can be added by careful examination of this rich resource, and it is
our sincere hope that others will soon explore the many facets of these imaging data.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources should be directed to and will be fulfilled by
the Lead Contact, Vésteinn Thorsson (Vesteinn.Thorsson@systemsbiology.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
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Human Subjects—A total of 4612 participants were included in this study. This study
contained both males and females, with inclusions of genders dependent on tumor types.
There were 2655 females and 1957 males. TCGA’s goal was to characterize adult human
tumors; therefore, the vast majority of participants were over the age of 18. However, one
participant under the age of 18 had tissue submitted prior to clinical data. Age was missing
for 40 participants. The range of ages was 15–90 (maximum set to 90 for protection of
human subjects) with a median age of diagnosis of 63 years of age. Institutional review
boards at each tissue source site reviewed protocols and consent documentation and
approved submission of cases to TCGA. Detailed clinical, pathologic and molecular
characterization of these participants, as well as inclusion criteria and quality control
procedures have been previously published for each of the individual TGCA cancer types.
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Sample Inclusion Criteria—Surgical resection of biopsy bio-specimens were collected
from patients that had not received prior treatment for their disease (ablation, chemotherapy,
or radiotherapy). Institutional review boards at each tissue source site reviewed protocols
and consent documentation and approved submission of cases to TCGA. Cases were staged
according to the American Joint Committee on Cancer (AJCC). Each frozen primary tumor
specimen had a companion normal tissue specimen (blood or blood components, including
DNA extracted at the tissue source site). Adjacent tissue was submitted for some cases.
Specimens were shipped overnight using a cryoport that maintained an average temperature
of less than −180°C.
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Pathology quality control was performed on each tumor and normal tissue (if available)
specimen from either a frozen section slide prepared by the BCR or from a frozen section
slide prepared by the Tissue Source Site (TSS). Hematoxylin and eosin (H&E) stained
sections from each sample were subjected to independent pathology review to confirm that
the tumor specimen was histologically consistent with the allowable hepatocellular
carcinomas and the adjacent tissue specimen contained no tumor cells. Adjacent tissue with
cirrhotic changes was not acceptable as a germline control, but was characterized if
accompanied by DNA from a patient-matched blood specimen. The percent tumor nuclei,
percent necrosis, and other pathology annotations were also assessed. Tumor samples with ≥
60% tumor nuclei and ≤ 20% or less necrosis were submitted for nucleic acid extraction.
METHOD DETAILS
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Image and Molecular Data Acquisition—Whole-slide tissue images were obtained
from the public TCGA Data Portal (images are currently available from the Genomic Data
Commons (GDC) Legacy Archive, following the deprecation of the TCGA Data Portal). Our
study uses the diagnostic images, with some images from frozen tissue specimens used in
the analysis of discrepancies with molecular estimates. The images were downloaded in the
native image format, Aperio SVS files, in which they had been scanned. An SVS file stores
an image in multiple resolutions, including the highest resolution the image data was
captured; for example in an image that is acquired at a 40x magnification, each pixel is
~0.25 × 0.25 microns. An open source library called OpenSlide (http://openslide.org/
formats/aperio/) was used to extract the highest resolution image data for our study. 5455
diagnostic slides were analyzed the 13 TCGA tumor types in the study.
Clinical and molecular data were obtained from processed and quality controlled files of the
PanCancer Atlas consortium, available at (https://gdc.cancer.gov/about-data/publications/
pancanatlas).
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Convolutional Neural Networks for TIL Maps—Our overall methodology consists of
two CNNs (a lymphocyte-infiltrated classification CNN (lymphocyte CNN) and a necrosis
segmentation CNN), as well as mechanisms for capturing and incorporating feedback from
pathologists, to evaluate and refine a generated Tumor-Infiltrating Lymphocyte (TIL) Map.
As is presented in the Results section, the lymphocyte CNN classifies image patches. Only
foreground patches are processed and classified. To determine if a patch is a foreground
patch, our analysis pipeline checks if the patch has enough tissue using the variance in Red,
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Green and Blue channels of the patch. A patch is labeled background and discarded if
(σ(Red) + σ(Green) + σ(Blue))/3 < 18. The values of the Red, Green, and Blue channels
range from 0 to 255. The threshold value of 18 was selected by adjusting it across several
slides. We compute percent TIL values using only the foreground patches (i.e., patches with
tissue). Note the set of patches with tissue includes TIL patches.
TIL % = (Number o f TIL Patches)/(Number o f Patches with Tissue)
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The lymphocyte CNN is a semi-supervised CNN, initialized by an unupervised
Convolutional Autoencoder (CAE). The CNN and the CAE are designed to have relatively
high resolution input such that one can recognize individual lymphocytes. We have chosen
to apply unsupervised CAE pre-training because many studies have shown that it boosts the
performance of the CNN, please refer to our technical report (Hou et al., 2017). Using the
lung adenocarcinoma (LUAD) patches, we empirically showed that the CNN without pretraining achieved significantly lower area under the curve (AUC). The CAE encodes
(compresses) an input image patch of 50 × 50 μm2 (100 × 100 square pixels, corresponding
to 20x magnification) into several vectors of length 100, and then reconstruct the input
image patch using these encoding vectors. We train the CAE in an unsupervised fashion, to
minimize the pixel-wise image patch reconstruction error, with limited number of encoding
vectors. By doing this, the CAE implicitly learns to encode the position, appearance and
morphology etc. of nuclei, in the encoding vectors. Our guideline of designing the
architecture of the CAE is that, each encoding vector, in the ideal case, should be capable of
encoding one and only one nucleus. As a result, the CAE has 13 encoding layers and 3
pooling layers. The lymphocyte CNN is built based on the trained CAE: we discard the
decoding (reconstruction) part of the CAE, and added several more layers on the encoding
vectors. Therefore, our lymphocyte CNN is a 18-layer network with 14 convolutional layers,
3 pooling layers, and 1 fully connected layer (Zhao et al., 2017).
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We use two different CNNs for classification of necrosis regions and TILs, because our
experiments showed necrosis regions and lymphocytes are best recognized and classified at
different image scales. The necrosis CNN model performs best with larger input tissue
regions, whereas the lymphocyte CNN model achieves the best results with local, highresolution image patches. The necrosis segmentation CNN is used to eliminate false
positives from the lymphocyte CNN in necrotic regions. In these regions, nuclei may have
characteristics similar to those in lymphocyte infiltrated regions. Because recognizing a
region of 50 × 50 μm2 need contextual information in a larger region, we model this as a
segmentation problem with larger input patches at a relatively lower resolution: 500 × 500
μm2 patches are extracted from the image and downsampled 3 times. The resulting patch is
333 × 333 pixels at 20x magnification. The necrosis segmentation CNN outputs pixel-wise
segmentation results. We use DeconvNet (Noh et al., 2015) for this task because it is
designed to predict pixel-wise class labels and handle structures and objects at multiple
scales (which is more suitable for segmentation than patch-level classification) and it has
been shown to achieve high prediction accuracy with several benchmark image datasets. We
train DeconvNet to classify each pixel as inside or outside a necrosis region. The output of
the necrosis segmentation CNN is resized to match the output resolution of the lymphocyte
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CNN. If over half of a 50x50 patch intersects with a necrotic region, the patch is classified as
non-lymphocyte-infiltrated.
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Convolutional Autoencoder Details—The Convolutional Autoencoder (CAE) contains
one branch with a small number of low resolution, dense features maps, and a second branch
with high resolution, but sparse feature maps The high resolution sparse feature maps are
designed to capture foreground objects (e.g., cancer cell nuclei and lymphocytes) - these
objects are sparsely distributed in the tissue and contain substantial high spatial frequency
color and texture variability. The network learns foreground feature maps in a “crosswise
sparse” manner: neurons across all feature maps are not activated (output zero) in most
feature map locations. Only neurons in a few feature map locations can be activated. Since
the non-activated neurons have no influence in the later decoding layers, the image
foreground is reconstructed using only the non-zero responses in the foreground encoding
feature maps. The low resolution dense feature maps are designed to encode background
color and texture of the background. We first model the background (tissue, cytoplasm etc.)
and then extract the foreground that contains nuclei.
The supervised CNN takes the unsupervised encoded features from the unsupervised CAE
for classification. We initialize the parameters in these layers to be the same as the
parameters in the CAE. We attach four 1x1 convolutional layers after the foreground
encoding layer and two 3x3 convolutional layers after the background encoding layer. Each
added layer has 320 convolutional filters. We then apply global average pooling on the two
branches. The pooled features are then concatenated together, followed by a final
classification layer with sigmoid activation function (Hou et al., 2017).
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CNN Training and Testing Details—We train our CAE on the unlabeled dataset,
minimizing the pixel-wise root mean squared error between the input images and the
reconstructed images. No regularization loss is deployed. We use stochastic gradient descent
with batch size 32, learning rate 0.03 and momentum 0.9, and train the network until
convergence (6 epochs).
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For the lymphocyte CNN (constructed from the CAE) training, we use stochastic gradient
descent with batch size 100, learning rate 0.001, and momentum 0.985. We train the CNN
until convergence (64 epochs) and divide the learning rate by 10 at the 20th, 32th, and 52th
epoch. We use sigmoid as the nonlinearity function in the last layer and log-likelihood as the
loss function. No regularization loss is deployed. We apply three types of data augmentation.
First, the input images are randomly cropped from a larger image. Second, the colors of the
input images are randomly perturbed. Third, we randomly rotate and mirror the input
images. We trained the CAE and CNN on a single Tesla K40 GPU. During testing phase, we
augmented the test patch 24 times and averaged the prediction results. The CAE and CNN
used the Theano library (http://deeplearning.net/software/theano/).
CNN-VGG Comparison Experiment Details—We fine-tuned the VGG 16-layer
network which was pre-trained on ImageNet. Fine-tuning the VGG16 network has been
shown to be robust for pathology image classification (Xu et.al. 2015; Hou et al., 2016b).
We used stochastic gradient descent with batch size 32, learning rate 0.0001, and momentum
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0.985. We trained the lymphocyte CNN until convergence (32 epochs). We used the same
loss function and data augmentation method used for the proposed CNN. To match the input
size of the VGG16 network, we re-sized the input patches from 100 × 100 pixels to 224 ×
224 pixels. Same as the proposed CNN, during testing phase, we augment the test patch 24
times and average the prediction results.
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Iterative Model Training and Data Labeling—We have implemented an iterative
workflow as depicted in Figure S1 in order to train the CNN models. First, an unsupervised
image analysis of WSIs is executed to initialize a CNN model. This model is refined in an
iterative process in which CNN predictions are reviewed, corrected and refined by expert
pathologists and the CNN model is re-trained with the updated data in order to improve its
classification performance. After a training phase, the CNN model is applied to patches in
the test set. For each test patch, the lymphocyte CNN produces a probability of the patch
being a lymphocyte-infiltrated patch. The label of the patch is decided by simple
thresholding; if the probability value is above a predefined threshold, the patch is classified
as lymphocyte-infiltrated.
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Training a fully supervised CNN requires a large number of training instances with ground
truth labels. Masci et al. (Masci et al., 2011) have shown that utilizing unlabeled instances
can boost the performance of a CNN. Drawing from those findings, we first trained an
unsupervised Convolutional Auto-Encoder (CAE) to learn the representation of nuclei and
lymphocytes in histopathology images and initialize the lymphocyte CNN (Zhao et al.,
2017). In this way, the initial lymphocyte CNN model captures the appearance of
histopathology images without supervised training. We initialized the weights of the necrosis
segmentation CNN randomly following the DeconvNet approach. We then trained the CNNs
with labeled images. The training phases of the CNNs involve a cross-validation step to
assess prediction performance and avoid overfitting (Hou et al., 2017).
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Review and Refinement of CNN Predictions—We developed a web application,
called the TIL-Map editor, to support the review and refinement by the pathologists of the
tumor-infiltrating lymphocyte patch predictions and the segmentation of necrotic regions.
The TIL-Map editor extends caMicroscope (Sharma et al., 2014) interface to enable the
visualization of patch-level classification labels as a heatmap overlay on a WSI. It is
distributed as part of a suite of tools called QuIP - Quantitative Imaging for Pathology (Saltz
et al., 2017). QuIP is an open-source software system which consists of a suite of integrated
data services and web-based user applications designed for the management and analysis of
whole-slide tissue images and indexing and exploration of image features. When using the
TIL-Map editor, a user can interactively visualize, pan, and zoom-in/out of the whole-slide
tissue image and interactively pan and zoom around the image, in a manner similar to
various online mapping systems. It display the TIL-Maps, as polygonal overlays that appear
over the H&E image. The intermediate and final TIL Maps are stored in the QuIP
FeatureDB, which manages and indexes both the image metadata and the TIL classification
results. Figure 2B shows an example heatmap along with the TIL-Map editor.
Each patch in a WSI is represented as a rectangle and associated with a classification label
and the probability value computed by the CNN. This information is stored as a data element
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(document) in FeatureDB and indexed to speed up queries by the TIL-Map editor to retrieve
and display subsets of patches. After classification results for a set of WSIs have been
loaded to the database, a pathologist can use a web browser to view and update the
classification results. The pathologist would use the TIL-Map editor to examine an image,
query FeatureDB to retrieve patches visible within the view point and zoom level and
display them as a two-color heatmap. The pathologist can edit the heatmap using the
“Lymphocyte Sensitivity,” “Necrosis Specificity,” “Smoothness” sliders in a panel. These
slides allow the pathologist to change the threshold value which determines if a patch should
be classified as lymphocyte-infiltrated or not. For finer-grain editing of individual patches or
sets of patches, the pathologist can use the “Markup Edit” function to markup specific
patches and label them as lymphocyte-infiltrated or not-lymphocyte-infiltrated. The
pathologist can then save the updated patch labels to the database. The updated patch labels
are used to retrain the CNN. Changes to the heatmap are only visible to the user him/herself:
multiple users can work independently selecting lymphocyte sensitivity and making finergrain editing in the same slide without knowing each other’s editing choices.
In this work, a team of three pathologists from Stony Brook Medicine and MD Anderson
Cancer Center reviewed and refined 10 to 20 WSIs in each cancer type using the TIL-Map
editor. Each image was assigned to two pathologists. Each pathologist separately adjusted
the “Lymphocyte Sensitivity,” “Necrosis Specificity,” “Smoothness” thresholds and
manually edited regions in the images using the “Markup Edit” tool in order to generate an
accurate patch-level classification in the entire image. Depending on the pathologists
consensus, if retraining was needed, the pathologists collaboratively generated a consensus
lymphocyte heatmap for each image. Data from these consensus heatmaps was input back to
the lymphocyte CNN in a training step to further improve its performance.
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Determining Lymphocyte Selection Thresholds—The trained lymphocyte and
necrosis CNNs was applied to 5455 diagnostic slides available for the 13 TCGA tumor types
in the study. We then determined selection thresholds based on overall probability estimates
for each slide to correct for possible slide-specific bias, in which the CNN was seen to
systematically over or under predicts lymphocytes depending on the overall characteristics
of the whole slide. The process of determining the lymphocyte selection thresholds is shown
in Figure S1. The first step is to classify each slide into categories that reflect whether there
is systematic over or under prediction of lymphocytes. To do this. for each slide, ten patches
were sampled from 10 ranges of the lymphocyte CNN’s scores (0.10–0.20, 0.20–0.25, 0.25–
0.30, 0.30–0.40, 0.40–0.50, 0.60–0.70, 0.70–0.80, 0.80–0.90, 0.90–1.00). Three pathologists
labeled them as lymphocyte infiltrated or not. Based on the number of labeled lymphocyte/
non-lymphocyte patches, each slide was categorized into 1 of 7 groups: Groups A-G, based
corresponding to 0,1,2,3–7,8,9, and 10 positive patches respectively. The second step is to
select a threshold in each group. In each group, we randomly selected 8 slides and manually
adjusted thresholds for each of them using our visual TIL-Map editor. The threshold of all
slides in one group was set to be the average threshold selected for the eight slides sampled
in that group. Note that if we categorize the slides into more number of groups, then we have
to manually select thresholds for more slides, since per group, a meaningful averaged
threshold requires a minimum number of selected thresholds. On the other hand, if we
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categorize the slides into fewer groups, the intra-group variance of possible slide-specific
biases might be too large. Therefore, we select seven as the number of groups, striking a
balance between efficiency and effectiveness.
Subsequent to processing as described above, incomplete TIL maps or those with failed
predictions were removed, and for LUAD additional manual review was performed to
remove TIL maps derived from poor slides, such as those that were out-of-focus or only
partially visible. This resulted in 5202 TIL maps (see Figure S1C, Table S2) for further
analysis and distribution. For a number of TCGA cases, multiple diagnostics slides are
available, distinguished by TCGA slide ID barcode suffixes DX1, DX2, …, DX13. All cases
have a DX1 diagnostic slide; hence these slides and corresponding TIL maps were used in
subsequent correlative analyses. The 5202 slide-derived TIL maps correspond to 4759
TCGA participants and slide IDs with suffix DX1.
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Molecular Data Estimates of Immune Response—We used estimates of tumor and
immune characteristics derived and made available in (Thorsson et al., 2018). The estimate
of TIL fraction by genomics measurements is obtained as described therein, by multiplying
overall leukocyte fraction derived from DNA methylation with an aggregated proportion of
immune-cell fractions within the immune compartment estimated using CIBERSORT
(Newman et al., 2015). The lymphocyte fraction is an aggregation of CIBERSORT estimates
of naive and memory B cells, naive, resting and activated memory CD4 T cells, follicular
helper T cells, T regulatory cells, gamma-delta T cells, CD8 T cells, activated and resting
NK cells and plasma cells. To compare with these data with TIL estimates from images,
participant and slide barcodes were restricted to those satisfying the inclusion criteria of the
TCGA PanCancer Atlas and Immune Response Working Group. Of the 4705 cases with
characterized TIL map clusters and patterns (see below), 4612 were thus available for
molecular data integration and comparison (Table S1, see also Figure S1C, Table S2).
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Local Spatial Structure of Immune Infiltrate—We used the APCluster R package
(Bodenhofer et al., 2011) to apply the affinity propagation algorithm to obtain local TIL
cluster patterns. The affinity propagation approach (Frey and Dueck, 2007) simultaneously
considers all data points as potential exemplars (i.e., the centers of clusters) from among
possible data points. Treating each data point as a node in a network, it recursively transmits
real-valued messages along edges of the network until it finds a good set of exemplars and
corresponding clusters. We define the similarities between data points (TIL patches) as the
negative square Euclidean distance between them. Aside from the similarity matrix itself,
the most important input parameter is the so-called “input preference” which can be
interpreted as the tendency of a data sample to become an exemplar. The function apcluster
in the package contains an argument q that allows setting the ‘input preference’ parameter to
a certain quantile of the input similarities: resulting in the median for q = 0.5 and in the
minimum for q = 0. To select this parameter, we generated synthetic data points in a plane
comprising two distinct Gaussian clouds of points. Using the synthetic data, we observed
that q = 0 was best able to cluster these points into two clusters, and used this value for
identifying TIL clusters. Of the 5202 TIL maps, 5144 clustering results were generated (see
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Figure S1C, Table S2), with the remainder failing to complete clustering runs in time or
failing due to memory errors, mostly in slides with numerous TILs.
Cluster characterization was made using simple measures of counts and membership and
cluster indices from the R package clusterCrit by Bernard Desgraupes. The Ball-Hall,
Banfield-Raftery, C Index, and Determinant Ration indices are detailed in the package
documentation.
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Variable

Definition or Reference

Number of TIL Patches

TIL patch count

TIL fraction

(TIL patch count)/(Total number of available patches on tissue slice)

Number of TIL Clusters

Number of clusters, from affinity propagation clustering

Cluster Size Mean

Mean of the cluster membership counts

Cluster Size Standard Deviation

Standard deviation of the cluster membership counts

Within-Cluster Dispersion Mean

Mean of the values of WGSSk, the within-cluster dispersion (see
below)

Within-Cluster Dispersion Standard Deviation

Standard deviation of the values of WGSSk

Cluster Extent Mean

Mean of the maximum distances to clusters exemplars. The cluster
examplar is the most representative TIL patch for the cluster, as
defined in the affinity propagation method

Cluster Extent Standard Deviation

Standard deviation of the maximum distances to exemplars

Ball Hall Index

Ball and Hall (1965). Available at: http://www.dtic.mil/docs/citations/
AD0699616

Banfield Raftery Index

Banfield and Raftery (1993)

C Index

Hubert and Schultz (1976)

Determinant Ratio Index

Scott and Symons (1971)

Ball Hall Index - TIL count adjusted

‘Adjusted’ refers to the residual of the corresponding index after
regression against %TIL density

Banfield Raftery Index - TIL count adjusted

‘Adjusted’ refers to the residual of the corresponding index after
regression against %TIL density

C Index - TIL count adjusted

‘Adjusted’ refers to the residual of the corresponding index after
regression against %TIL density

Determinant Ratio Index - TIL count adjusted

‘Adjusted’ refers to the residual of the corresponding index after
regression against %TIL density
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In the above, WGSSk is a within-cluster dispersion which is the sum of the squared distances
between the observations and the barycenter of the cluster (see https://CRAN.R-project.org/
package=clusterCrit) for details. To compute the adjusted indices, linear regression was used
to model the relationship between the clustering index and the %TIL density. The regression
residual was used as the adjusted index. Cluster characteristic were generated for all 5144
slides with cluster results (4705 with DX1 suffix)(see Figure S1C, Table S2) and adjusted
indices for 4509 cases.
Assessment of TIL Map Structural Patterns—In order to perform a comprehensive
assessment of the TIL map structural patterns, the collection of 5202 H&E images (see
above, 4759 with DX1 suffix) and the corresponding TIL maps were visually inspected to
ensure that each H&E image had a correctly matched TIL map, after which, a subset of 500
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H&E images and corresponding TIL maps were closely inspected at higher power
magnification (100x to 200x) in 30–50 fields to ensure that the lymphocyte-detection
algorithm was performing as intended and not mistakenly identifying tumor cells as
lymphocytes across the various tumor types as a quality-control measure. We further
employed H&E images and corresponding TIL maps from cases of uveal melanoma as
negative controls because melanoma tumor cells and melanotic pigment can be a difficult
challenge for the lymphocyte-detection algorithm.
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After the negative controls were verified and quality measures were satisfactorily addressed,
TIL maps (total N = 4455) were assessed in a two part fashion by a qualitative description
and a semiquantitative score based on visual inspection with respect to the tumor region
only, which is determined by histopathologic evaluation at low-power magnification (40x) of
the corresponding H&E diagnostic whole-slide image. The tumor region represents the
combined intra-tumoral and peri-tumoral regions and excludes the adjacent non-tumor
regions.
The qualitative description characterizes the nature of the immune infiltrate with respect to
the gross spatial distribution of the TILs in only the tumor region with terms like “Focal”
(localized), “Multi-focal” (loosely scattered), “Diffuse” (spread out over a large area), and
“Band-like” (well-defined boundaries bordering the tumor at its periphery). The
semiquantitative scoring evaluates the relative strength of the immune response terms like
“None,” “Non-brisk” (minimal to mild partial immune response), and “Brisk” (moderate to
strong immune response).
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Taken together, “Non-brisk, focal” is indicative of a “very weak” but minimally present
immune response with a low density of TILs in a localized area of the tumor, whereas “Nonbrisk, multi-focal” is indicative of a weak partial immune response with loosely scattered
TILs in a few areas of the tumor. However, “Brisk, diffuse” represents a moderate to strong
immune response with a relatively dense and spread out pattern of TILs across > 30% of the
tumor even if there are band-like boundaries bordering the tumor at its periphery. The
“Brisk, band-like” description was reserved for cases where the TIL map patterns showed
relatively organized structures that appear as boundaries bordering the tumor at its periphery
and < 30% TILs in the intra-tumoral component. “None” was selected in cases where few
TILs were present in less than 1% of the area of the tumor and “Indeterminate” was used if
there was insufficient or no grossly identifiable tumor in the H&E image at low-power with
the corresponding TIL map regardless of pattern and semiquantitative distribution of TILs.
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Summary Table of Criteria Used to Characterize TIL Map Structural Patterns

Category

Immune Response

Qualitative Pattern

Proportion of Tumor
composed of
Lymphocytes

Indeterminate

Insufficient and/or no tumor
in the H&E image at lowpower

Not applicable

Not applicable

None

No response

No pattern

<1% TILs
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Category

Immune Response

Qualitative Pattern

Proportion of Tumor
composed of
Lymphocytes

Non-brisk, focal

Very Weak (minimal)

Localized

<5% TILs

Non-brisk, multi-focal

Weak (mild)

Loosely scattered foci

>5%–30% TILs

Brisk, diffuse

Moderate to Strong

Diffuse and dense infiltrate

>30% TILs in the intratumoral component*

Brisk, band-like

Not applicable

Infiltrate bordering the tumor
at its periphery

<30% TILs in the intratumoral component*

*

If the TIL map patterns revealed both diffuse and band-like immune responses, the predominant pattern was characterized
and the difference between “Brisk, diffuse” and “Brisk, band-like” was based on whether the relative distribution of TILs in
the intra-tumoral component appeared to be greater than or less than 30%, respectively.

DATA AND SOFTWARE AVAILABILITY

Author Manuscript

The original H&E stained whole-slide images used in this work can be downloaded from the
Genomic Data Commons. All TCGA molecular data can be obtained from the Genomic
Data Commons, as well as derived data matrices of the PanCancer Atlas. Integration with
immune signatures of the TCGA immune response working group is available through CRI
iAtlas web resource. Links to these data resources can be found at the accompanying
publication manuscript page (https://gdc.cancer.gov/about-data/publications/tilmap).
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The analysis codes used in this work is version controlled has also been containerized and
made available as a Docker image. The QuIP software for iterative refinement of CNN
prediction results is also available. The training datasets for the CNN models and the TIL
maps generated in this study are also available for download. These different software
resources as well as the TIL maps are available on the Cancer Imaging Archive, at: https://
doi.org/10.7937/K9/TCIA.2018.Y75F9W1
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical details of all experiments are reported in the text, figure legends and figures,
including statistical analysis performed, statistical significance and counts.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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BLCA

Bladder urothelial carcinoma

BRCA

Breast invasive carcinoma

CESC

Cervical squamous cell carcinoma and endocervical adenocarcinoma

COAD

Colon adenocarcinoma

LUAD

Lung adenocarcinoma

LUSC

Lung squamous cell carcinoma

PAAD

Pancreatic adenocarcinoma

PRAD

Prostate adenocarcinoma

READ

Rectum adenocarcinoma

SKCM

Skin Cutaneous Melanoma

STAD

Stomach adenocarcinoma

UCEC

Uterine Corpus Endometrial Carcinoma

UVM

Uveal Melanoma
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Highlights
•

Deep learning based computational stain for staining tumorinfiltrating
lymphocytes (TILs)

•

TIL patterns generated from 4,759 TCGA subjects (5,202 H& slides), 13
cancer types

•

Computationally stained TILs correlate with pathologist eye and molecular
estimates

•

TIL patterns linked to tumor and immune molecular features, cancer type, and
outcome
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Figure 1. Workflow for Training, Model Development, and Subsequent Generation of TIL Maps
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Top: for training and developing CNN models, a pathologist reviews images and marks
regions with lymphocytes and necrosis. These training data are then broken down into
patches that are then fed into a training stage to train CNNs for lymphocyte and necrosis
detection. A pathologist periodically reviews the results for accuracy and corrects the
prediction. This results in a pair of Trained CNNs. Bottom: these trained CNNs are then
used on the full set of 5,455 images from 13 cancer types to generate TIL maps. During TIL
map generation, a probability map for TILs is generated from each image. These
probabilities are then reviewed and lymphocyte selection thresholds are established using a
selective sampling strategy (further information in Method Details). These thresholds are
then used to obtain the final TIL maps. See also Figure S1 and Tables S1 and S2.
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Figure 2. Assessment of TIL Prediction

(A) Receiver Operating Characteristic depicting performance of CNN. Applied to TCGA
lung adenocarcinoma patches. The current method is compared with a popular CNN called
VGG16 (see main text description).
(B) Comparison of TIL scores of super-patches between pathologists and computational
stain. x axis: median scores from three pathologists assessing 400 super-patches as having
low, medium, or high lymphocyte infiltrate. y axis: scores from computational staining, on a
scale from 0 to 64.
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Figure 3. TIL Fraction by Tumor Category

(A–E) Percent TIL fraction, the proportion of TIL-positive patches within a TIL map, is
shown by various categorizations of TCGA tumor samples. Each plotted point represents a
tumor sample for (A) 13 TCGA tumor types (4,612 cases), (B) six subtypes characterized by
differences in the nature of the overall immune response (Thorsson et al., 2018) (C5 has very
few samples here), (C) gastrointestinal adenocarcinoma subtypes, (D) lung squamous cell
carcinoma subtypes, and (E) breast adenocarcinoma subtypes. See also Figure S2.
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Figure 4. Comparison of TIL Proportion from Imaging and Molecular Estimates
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(A) Spearman correlation coefficients and p values for comparison of TIL fraction from
spatial estimates of TIL maps and molecular estimates of TIL fraction from processing of
cancer genomics data using deconvolution methods (see main text).
(B) Each point represents a breast adenocarcinoma tumor sample, with the value of TIL
fraction from TIL maps (x axis) and from molecular estimates (y axis).
(C) As in B for 12 additional TCGA tumor types. See also Figure S3 and the companion
manuscript (Thorsson et al., 2018).
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Figure 5. Examples of TIL Map Structural Patterns
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(A–D) Four cases representing different degrees of lymphocyte infiltration. Each example is
labeled by TCGA participant barcode and has the following three panels. Left: H&E
diagnostic image at low magnification with tumor regions circled in yellow; middle: TIL
map; red represents a positive TIL patch, blue represents a tissue region with no TIL patch,
while black represents no tissue; right: diagrams of clusters of TIL patches derived from the
affinity propagation clustering of the TIL patches. Line segments connect cluster members
with a central representative for each cluster, and colors are arbitrarily assigned to aid visual
separation of clusters.
(E) TIL map, cluster statistics, and global patterns for the four examples in A–D. Each
column represents one way to characterize the TIL map, ranging from simple measures such
as TIL count and density to more complex ones characterizing details of cluster properties
and image patterns (see main text). See also Table S2.
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Figure 6. Associations of TIL Local Spatial Structure with Cancer Type and Survival
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Associations are shown with cluster indices, which summarize properties of clusters derived
from affinity propagation clusters of the TIL map—properties that provide details on local
structure beyond simple densities.
(A) Ball-Hall cluster indices for all slide images considered in the study. The Ball-Hall index
is a particular clustering index, summarizing the mean, through all the clusters, of their mean
dispersion and is equivalent to the mean of the squared distances of the points of the cluster
with respect to its center. In our data, the Ball-Hall index is correlated (ρSpearman = 0.95)
with the mean cluster extent, CE.
(B) Table of significant associations between TIL fraction-adjusted cluster indices and
overall survival based on Cox regression, accounting for age and gender as additional
clinical covariates.
(C) Overall survival for median-stratified TIL fraction-adjusted Ball-Hall index in breast
cancer. Significance test p value is shown in the lower left.
(D) Same as C but for adjusted Banfield-Raftery index in skin cutaneous melanoma. The
Banfield-Raftery index is the weighted sum of the logarithms of the mean cluster dispersion
and, in our data, often correlates with the number of clusters. See also Figure S4.
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Figure 7. Association of Spatial Structural Patterns with Tumor Type and Cell Fractions
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(A) Each row corresponds to one of four spatial structure patterns, assigned in a manner
consistent with the descriptions currently used to characterize the nature of the immune
infiltrate in standard histopathological examinations, and each column is a TCGA tumor
types. The values shown are the sample count for each tumor type and spatial structure
pattern, divided by the counts expected by chance. The ratio of observed to expected comembership counts is shown on a color scale, where the largest ratios are in red, values near
unity as yellow, and blue represents fewer than expected counts.
(B) Estimates of the proportion of CD4, CD8, NK cells, and B cells were segregated by
spatial structure patterns and averaged. Bars show the proportion within each structural
pattern. These proportions are estimated using molecular data of the TCGA. See also Figure
S5.
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